Skip to main content

Table 3 Relationships of the presence of anti-Bmi-1 autoantibody with clinicopathologic variables.

From: Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma

    Anti-Bmi-1  
Characteristics Total (n = 159) OD ± SD Negative cases 61.0% Positive cases 39.0% P
Stage      0.040
   I 6 0.1883 ± 0.0459 6(100) 0(0.0)  
   II 72 0.2274 ± 0.0795 46(63.9) 26(36.1)  
   III 69 0.2394 ± 0.0932 39(56.5) 30(43.5)  
   IV 12 0.2441 ± 0.0755 5(41.7) 7(58.3)  
pT classification      0.747
   T1 9 0.1983 ± 0.0552 8(88.9) 1(11.1)  
   T2 40 0.2312 ± 0.0815 22(55.0) 18(45.0)  
   T3 80 0.2389 ± 0.0857 49(61.2) 31(38.8)  
   T4 30 0.2230 ± 0.0927 18(60.0) 12(40.0)  
pN classification      <0.001
   YES 75 0.2596 ± 0.0826 35(46.7) 40(53.3)  
   NO 84 0.2067 ± 0.0787 62(73.8) 22(26.2)  
pMetastasis      0.170
   YES 12 0.2441 ± 0.0755 5(41.7) 7(58.3)  
   NO 147 0.2385 ± 0.0858 91(61.9) 56(38.1)  
\